{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T14:10:08Z","timestamp":1749910208947,"version":"3.41.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,14]]},"DOI":"10.7759\/cureus.86000","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T13:34:43Z","timestamp":1749908083000},"source":"Crossref","is-referenced-by-count":0,"title":["Ductal Adenocarcinoma of the Prostate Presenting With Bladder Invasion and Bone Metastasis: A Case Report"],"prefix":"10.7759","author":[{"given":"Vinesia L","family":"Riddi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward  U","family":"Harahap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Sitinjak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ros","family":"Nirmawati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/bco2.60","article-title":"Ductal adenocarcinoma of the prostate: A systematic review and meta-analysis of incidence, presentation, prognosis, and management","volume":"2","author":"Ranasinha N","year":"2021","unstructured":"Ranasinha N, Omer A, Philippou Y, et al.. Ductal adenocarcinoma of the prostate: A systematic review and meta-analysis of incidence, presentation, prognosis, and management. BJUI Compass. 2021, 2:13-23. 10.1002\/bco2.60","journal-title":"BJUI Compass"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.08.017","article-title":"Ductal adenocarcinoma of the prostate: increased mortality risk and decreased serum prostate specific antigen","volume":"184","author":"Morgan TM","year":"2010","unstructured":"Morgan TM, Welty CJ, Vakar-Lopez F, Lin DW, Wright JL. Ductal adenocarcinoma of the prostate: increased mortality risk and decreased serum prostate specific antigen. J Urol. 2010, 184:2303-7. 10.1016\/j.juro.2010.08.017","journal-title":"J Urol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.1000-9604.2016.02.02","article-title":"The update of prostatic ductal adenocarcinoma","volume":"28","author":"Liu T","year":"2016","unstructured":"Liu T, Wang Y, Zhou R, Li H, Cheng H, Zhang J. The update of prostatic ductal adenocarcinoma. Chin J Cancer Res. 2016, 28:50-7. 10.3978\/j.issn.1000-9604.2016.02.02","journal-title":"Chin J Cancer Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol31030118","article-title":"Ductal Adenocarcinoma of the Prostate with Novel Genetic Alterations Characterized by Next-Generation Sequencing","volume":"31","author":"Zara Rozalen A","year":"2024","unstructured":"Zara Rozalen A, Martin JM, Rajendran R, Jain M, Nava VE. Ductal Adenocarcinoma of the Prostate with Novel Genetic Alterations Characterized by Next-Generation Sequencing. Curr Oncol. 2024, 31:1556-61. 10.3390\/curroncol31030118","journal-title":"Curr Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2011.10520.x","article-title":"Incidence and outcomes of ductal carcinoma of the prostate in the USA: analysis of data from the Surveillance, Epidemiology, and End Results program","volume":"109","author":"Meeks JJ","year":"2012","unstructured":"Meeks JJ, Zhao LC, Cashy J, Kundu S. Incidence and outcomes of ductal carcinoma of the prostate in the USA: analysis of data from the Surveillance, Epidemiology, and End Results program. BJU Int. 2012, 109:831-4. 10.1111\/j.1464-410X.2011.10520.x","journal-title":"BJU Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.eucr.2016.03.012","article-title":"Ductal Adenocarcinoma of the Prostate With a Rare Clinical Presentation; Late Gastric Metastasis","volume":"7","author":"Tavukcu HH","year":"2016","unstructured":"Tavukcu HH, Aytac O, Aktepe F, Atug F, Erdem L, Tecimer C. Ductal Adenocarcinoma of the Prostate With a Rare Clinical Presentation; Late Gastric Metastasis. Urol Case Rep. 2016, 7:28-30. 10.1016\/j.eucr.2016.03.012","journal-title":"Urol Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5173\/ceju.2013.02.art14","article-title":"An incidentally diagnosed prostatic ductal adenocarcinoma","volume":"66","author":"Stajno P","year":"2013","unstructured":"Stajno P, Kalinowski T, Ligaj M, Demkow T. An incidentally diagnosed prostatic ductal adenocarcinoma. Cent European J Urol. 2013, 66:164-7. 10.5173\/ceju.2013.02.art14","journal-title":"Cent European J Urol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32957","article-title":"Patterns of metastases of prostatic ductal adenocarcinoma","volume":"126","author":"Ranasinghe WK","year":"2020","unstructured":"Ranasinghe WK, Brooks NA, Elsheshtawi MA, et al.. Patterns of metastases of prostatic ductal adenocarcinoma. Cancer. 2020, 126:3667-73. 10.1002\/cncr.32957","journal-title":"Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2016.04.001","article-title":"Ductal adenocarcinoma of the prostate: histogenesis, biology and clinicopathological features","volume":"48","author":"Seipel AH","year":"2016","unstructured":"Seipel AH, Delahunt B, Samaratunga H, Egevad L. Ductal adenocarcinoma of the prostate: histogenesis, biology and clinicopathological features. Pathology. 2016, 48:398-405. 10.1016\/j.pathol.2016.04.001","journal-title":"Pathology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/his.12382","article-title":"Diagnostic criteria for ductal adenocarcinoma of the prostate: interobserver variability among 20 expert uropathologists","volume":"65","author":"Seipel AH","year":"2014","unstructured":"Seipel AH, Delahunt B, Samaratunga H, et al.. Diagnostic criteria for ductal adenocarcinoma of the prostate: interobserver variability among 20 expert uropathologists. Histopathology. 2014, 65:216-27. 10.1111\/his.12382","journal-title":"Histopathology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S4716","article-title":"Ductal adenocarcinoma of the prostate: Immunohistochemical findings and clinical significance","volume":"6","author":"Sha J","year":"2013","unstructured":"Sha J, Bo J, Pan J, et al.. Ductal adenocarcinoma of the prostate: Immunohistochemical findings and clinical significance. Onco Targets Ther. 2013, 6:1501-1506. 10.2147\/OTT.S4716","journal-title":"Onco Targets Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/pros.24869","article-title":"The Prognostic Value of the Prostate Adenocarcinoma With Ductal Feature in Patients With Advanced Prostate Cancer Treated With Abiraterone Acetate","volume":"85","author":"Shi Y","year":"2025","unstructured":"Shi Y, Wei X, Zhao F, et al.. The Prognostic Value of the Prostate Adenocarcinoma With Ductal Feature in Patients With Advanced Prostate Cancer Treated With Abiraterone Acetate. Prostate. 2025, 85:659-69. 10.1002\/pros.24869","journal-title":"Prostate"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.30699\/ijp.2020.123998.2353","article-title":"Comparison of Immunohistochemistry Expression of CK7, HMWK and PSA in High-Grade Prostatic Adenocarcinoma and Bladder Transitional Cell Carcinoma","volume":"16","author":"Gheitasi R","year":"2021","unstructured":"Gheitasi R, Sadeghi E, Jafari M. Comparison of Immunohistochemistry Expression of CK7, HMWK and PSA in High-Grade Prostatic Adenocarcinoma and Bladder Transitional Cell Carcinoma. Iran J Pathol. 2021, 16:33-9. 10.30699\/ijp.2020.123998.2353","journal-title":"Iran J Pathol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2013.1557","article-title":"A novel subtype of primary prostatic adenocarcinoma: A case report","volume":"6","author":"Yang X","year":"2013","unstructured":"Yang X, Xu C, Guo J, Yang C, Yang Y, Han R. A novel subtype of primary prostatic adenocarcinoma: A case report. Oncol Lett. 2013, 6:1303-6. 10.3892\/ol.2013.1557","journal-title":"Oncol Lett"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/363748-ductal-adenocarcinoma-of-the-prostate-presenting-with-bladder-invasion-and-bone-metastasis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T13:34:44Z","timestamp":1749908084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/363748-ductal-adenocarcinoma-of-the-prostate-presenting-with-bladder-invasion-and-bone-metastasis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,14]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.86000","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,14]]}}}